Commentary: Thinking through Public Health Genomics.

The author discusses perspectives related to public health genomics, medical anthropology, and science studies. Topics include the role of for-profit innovations in re-creating personal risk profile for diseases and drug metabolism, an interview by periodical editor Sandra Lee with consumers of gene...

Descripción completa

Detalles Bibliográficos
Publicado en:Medical Anthropology Quarterly Vol. 27; no. 4; pp. 573 - 577
Autor principal: Rapp, Rayna
Formato: Artículo
Publicado: Wiley-Blackwell Dec2013
Materias:
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ssf&AN=94728204&site=ehost-live
header:
  @attributes:
    shortDbName: ssf
    uiTerm: 94728204
    longDbName: Social Sciences Full Text (H.W. Wilson)
    uiTag: AN
  controlInfo:
    bkinfo:
    jinfo:
      jid:
        07455194
        GFS
      jtl: Medical Anthropology Quarterly
      issn: 07455194
      maglogo: Y
    pubinfo:
      dt: Dec2013
      vid: 27
      iid: 4
      pid: 480
      pub: Wiley-Blackwell
    artinfo:
      ui:
        94728204
        10.1111/maq.12062
      ppf: 573
      ppct: 4
      formats:
        fmt:
          @attributes:
            type: P
            size: 60KB
      tig:
        atl: Commentary: Thinking through Public Health Genomics.
      aug:
        au: Rapp, Rayna
        affil: Department of Anthropology, New York University
      su:
        Lee, Sandra, 1966-
        23 & Me Inc.
        Public health
        Genomics
        Medical anthropology
        Drug metabolism
        DNA
      sug:
        subj:
          Public health
          23 & Me Inc.
          Health and Welfare Funds
          Genomics
          Medical anthropology
          Drug metabolism
          DNA
          Lee, Sandra, 1966-
      ab: The author discusses perspectives related to public health genomics, medical anthropology, and science studies. Topics include the role of for-profit innovations in re-creating personal risk profile for diseases and drug metabolism, an interview by periodical editor Sandra Lee with consumers of genetic testing company 23&Me, and the use of admixture technologies in probing DNA samples.
      pubtype: Academic Journal
      doctype: Article
      src: R
    language: English
    refInfo:
    copyright:
      @attributes:
        flag: N
    holdings:
      @attributes:
        islocal: N